AKRO Financial Statements

Balance sheet, income statement, cash flow, and dividends for Akero Therapeutics Inc (AKRO).


$1.94B Market Cap.

As of 03/01/2025 5:00 PM ET (MRY) • Disclaimer

AKRO Market Cap. (MRY)


AKRO Shares Outstanding (MRY)


AKRO Assets (MRY)


Total Assets

$825.89M

Total Liabilities

$75.77M

Total Investments

$457.59M

AKRO Income (MRY)


Revenue

$0

Net Income

-$252.06M

Operating Expense

$285.42M

AKRO Cash Flow (MRY)


CF Operations

-$230.11M

CF Investing

-$109.71M

CF Financing

$445.85M

AKRO Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

AKRO Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$825,886,000 (42.33%)

$580,271,000 (62.74%)

$356,570,000 (82.34%)

$195,548,000 (-28.46%)

Assets Current

$770,380,000 (37.58%)

$559,962,000 (57.66%)

$355,173,000 (83.47%)

$193,582,000 (-28.66%)

Assets Non-Current

$55,506,000 (173.31%)

$20,309,000 (1353.76%)

$1,397,000 (-28.94%)

$1,966,000 (-1.40%)

Goodwill & Intangible Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Shareholders Equity

$750,112,000 (40.13%)

$535,306,000 (63.92%)

$326,562,000 (93.11%)

$169,109,000 (-34.63%)

Property Plant & Equipment Net

$755,000 (-26.41%)

$1,026,000 (-20.40%)

$1,289,000 (-16.79%)

$1,549,000 (-13.61%)

Cash & Equivalents

$340,238,000 (45.27%)

$234,207,000 (-6.23%)

$249,773,000 (65.98%)

$150,483,000 (-19.63%)

Accumulated Other Comprehensive Income

$948,000 (251.11%)

$270,000 (629.73%)

$37,000 (237.04%)

-$27,000 (-800.00%)

Deferred Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Investments

$457,591,000 (36.56%)

$335,086,000 (229.56%)

$101,676,000 (169.16%)

$37,775,000 (-53.45%)

Investments Current

$402,840,000 (27.56%)

$315,803,000 (210.60%)

$101,676,000 (169.16%)

$37,775,000 (-53.45%)

Investments Non-Current

$54,751,000 (183.93%)

$19,283,000 (0%)

$0 (0%)

$0 (0%)

Inventory

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Payables

$9,027,000 (28.26%)

$7,038,000 (-11.67%)

$7,968,000 (18.82%)

$6,706,000 (95.62%)

Accumulated Retained Earnings (Deficit)

-$826,156,000 (-43.91%)

-$574,096,000 (-35.93%)

-$422,337,000 (-36.10%)

-$310,304,000 (-48.10%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$35,826,000 (38.95%)

$25,783,000 (142.78%)

$10,620,000 (710.07%)

$1,311,000 (-13.52%)

Debt Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Debt Non-Current

$35,826,000 (38.95%)

$25,783,000 (142.78%)

$10,620,000 (710.07%)

$1,311,000 (-13.52%)

Total Liabilities

$75,774,000 (68.52%)

$44,965,000 (49.84%)

$30,008,000 (13.50%)

$26,439,000 (80.75%)

Liabilities Current

$39,754,000 (107.83%)

$19,128,000 (0.24%)

$19,083,000 (-24.06%)

$25,128,000 (91.66%)

Liabilities Non-Current

$36,020,000 (39.41%)

$25,837,000 (136.49%)

$10,925,000 (733.33%)

$1,311,000 (-13.52%)

AKRO Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Cost of Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Selling General & Administrative Expense

$37,926,000 (22.06%)

$31,072,000 (4.02%)

$29,872,000 (56.18%)

$19,127,000 (25.52%)

Research & Development Expense

$247,497,000 (74.54%)

$141,798,000 (66.27%)

$85,284,000 (4.31%)

$81,759,000 (25.95%)

Operating Expenses

$285,423,000 (65.11%)

$172,870,000 (50.12%)

$115,156,000 (14.14%)

$100,886,000 (25.87%)

Interest Expense

$4,668,000 (50.63%)

$3,099,000 (319.35%)

$739,000 (0%)

$0 (0%)

Income Tax Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$252,060,000 (-66.09%)

-$151,759,000 (-35.46%)

-$112,033,000 (-11.17%)

-$100,777,000 (-27.23%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$252,060,000 (-66.09%)

-$151,759,000 (-35.46%)

-$112,033,000 (-11.17%)

-$100,777,000 (-27.23%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$252,060,000 (-66.09%)

-$151,759,000 (-35.46%)

-$112,033,000 (-11.17%)

-$100,777,000 (-27.23%)

Weighted Average Shares

$67,136,772 (27.71%)

$52,568,159 (34.84%)

$38,984,772 (11.94%)

$34,827,385 (10.69%)

Weighted Average Shares Diluted

$67,136,772 (27.71%)

$52,568,159 (34.84%)

$38,984,772 (11.94%)

$34,827,385 (10.69%)

Earning Before Interest & Taxes (EBIT)

-$247,392,000 (-66.41%)

-$148,660,000 (-33.57%)

-$111,294,000 (-10.44%)

-$100,777,000 (-27.23%)

Gross Profit

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Operating Income

-$285,423,000 (-65.11%)

-$172,870,000 (-50.12%)

-$115,156,000 (-14.14%)

-$100,886,000 (-25.87%)

AKRO Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

-$109,708,000 (50.94%)

-$223,623,000 (-250.37%)

-$63,825,000 (-250.96%)

$42,280,000 (533.15%)

Net Cash Flow from Financing

$445,846,000 (26.19%)

$353,316,000 (38.21%)

$255,632,000 (42363.79%)

$602,000 (-99.70%)

Net Cash Flow from Operations

-$230,107,000 (-58.29%)

-$145,367,000 (-57.12%)

-$92,517,000 (-16.11%)

-$79,681,000 (-12.54%)

Net Cash Flow / Change in Cash & Cash Equivalents

$106,031,000 (776.48%)

-$15,674,000 (-115.79%)

$99,290,000 (369.82%)

-$36,799,000 (-130.03%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

-$108,709,000 (51.39%)

-$223,623,000 (-250.37%)

-$63,825,000 (-250.96%)

$42,280,000 (539.82%)

Capital Expenditure

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Issuance (Repayment) of Debt Securities

$10,000,000 (-33.33%)

$15,000,000 (56.17%)

$9,605,000 (0%)

$0 (0%)

Issuance (Purchase) of Equity Shares

$436,690,000 (28.78%)

$339,092,000 (37.68%)

$246,284,000 (21830.90%)

$1,123,000 (-99.45%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$29,698,000 (38.15%)

$21,497,000 (-7.51%)

$23,243,000 (131.18%)

$10,054,000 (66.95%)

Depreciation Amortization & Accretion

$271,000 (3.04%)

$263,000 (1.15%)

$260,000 (6.56%)

$244,000 (14.55%)

AKRO Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

-

-

-

-

Profit Margin

-

-

-

-

EBITDA Margin

-

-

-

-

Return on Average Equity (ROAE)

-32.20% (-8.42%)

-29.70% (35.99%)

-46.40% (3.93%)

-48.30% (-16.95%)

Return on Average Assets (ROAA)

-29.50% (-8.46%)

-27.20% (33.82%)

-41.10% (6.80%)

-44.10% (-13.37%)

Return on Sales (ROS)

-

-

-

-

Return on Invested Capital (ROIC)

-54.10% (5.42%)

-57.20% (89.79%)

-560.30% (-155.84%)

-219.00% (-95.54%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-7.42 (8.18%)

-8.08 (57.68%)

-19.09 (-160.92%)

-7.32 (28.52%)

Price to Sales Ratio (P/S)

-

-

-

-

Price to Book Ratio (P/B)

2.59 (6.54%)

2.43 (-69.03%)

7.85 (79.85%)

4.36 (25.99%)

Debt to Equity Ratio (D/E)

0.1 (20.24%)

0.08 (-8.70%)

0.09 (-41.03%)

0.16 (173.68%)

Earnings Per Share (EPS)

-3.75 (-29.76%)

-2.89 (-0.70%)

-2.87 (0.69%)

-2.89 (-14.68%)

Sales Per Share (SPS)

0 (0%)

0 (0%)

0 (0%)

0 (0%)

Free Cash Flow Per Share (FCFPS)

-3.43 (-23.94%)

-2.77 (-16.52%)

-2.37 (-3.72%)

-2.29 (-1.46%)

Book Value Per Share (BVPS)

11.17 (9.72%)

10.18 (21.56%)

8.38 (72.51%)

4.86 (-40.95%)

Tangible Assets Book Value Per Share (TABVPS)

12.3 (11.45%)

11.04 (20.69%)

9.15 (62.89%)

5.62 (-35.37%)

Enterprise Value Over EBIT (EV/EBIT)

-7 (0.00%)

-7 (65.00%)

-20 (-233.33%)

-6 (33.33%)

Enterprise Value Over EBITDA (EV/EBITDA)

-6.72 (5.62%)

-7.12 (64.04%)

-19.81 (-246.70%)

-5.71 (35.96%)

Asset Turnover

0 (0%)

0 (0%)

0 (0%)

0 (0%)

Current Ratio

19.38 (-33.80%)

29.27 (57.29%)

18.61 (141.59%)

7.7 (-62.78%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$230,107,000 (-58.29%)

-$145,367,000 (-57.12%)

-$92,517,000 (-16.11%)

-$79,681,000 (-12.30%)

Enterprise Value (EV)

$1,661,475,297 (57.19%)

$1,057,009,433 (-51.94%)

$2,199,206,593 (282.93%)

$574,317,587 (-18.50%)

Earnings Before Tax (EBT)

-$252,060,000 (-66.09%)

-$151,759,000 (-35.46%)

-$112,033,000 (-11.17%)

-$100,777,000 (-27.23%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$247,121,000 (-66.53%)

-$148,397,000 (-33.65%)

-$111,034,000 (-10.45%)

-$100,533,000 (-27.27%)

Invested Capital

$481,720,000 (36.57%)

$352,719,000 (258.69%)

$98,334,000 (362.79%)

$21,248,000 (-71.48%)

Working Capital

$730,626,000 (35.09%)

$540,834,000 (60.92%)

$336,090,000 (99.51%)

$168,454,000 (-34.77%)

Tangible Asset Value

$825,886,000 (42.33%)

$580,271,000 (62.74%)

$356,570,000 (82.34%)

$195,548,000 (-28.46%)

Market Capitalization

$1,941,812,297 (49.28%)

$1,300,823,433 (-49.24%)

$2,562,622,593 (247.29%)

$737,887,587 (-17.63%)

Average Equity

$783,189,250 (53.47%)

$510,305,750 (111.53%)

$241,244,250 (15.72%)

$208,472,500 (8.70%)

Average Assets

$855,179,750 (53.52%)

$557,056,500 (104.14%)

$272,885,000 (19.33%)

$228,678,250 (12.37%)

Invested Capital Average

$457,118,500 (75.91%)

$259,852,000 (1208.17%)

$19,863,750 (-56.84%)

$46,023,500 (-34.93%)

Shares

69,799,148 (25.29%)

55,709,783 (19.13%)

46,763,186 (34.04%)

34,888,302 (0.48%)